These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9636473

  • 1. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
    Rostaing L, Chabannier MH, Modesto A, Rouzaud A, Cisterne JM, Tkaczuk J, Durand D.
    Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
    [No Abstract] [Full Text] [Related]

  • 2. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M, Tanabe K, Ishikawa N, Tokumoto T, Harano M, Otsubo S, Suzuki K, Goya N, Yagisawa T, Nakazawa H, Fuchinoue S, Toma H.
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract] [Full Text] [Related]

  • 3. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.
    Uslu A, Tokat Y, Ok E, Unsal A, Ilkgul O, Kaplan H.
    Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
    Carvalho MF, Adoni T, Saggioro FP, Soares V.
    Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607
    [No Abstract] [Full Text] [Related]

  • 5. Correlation between Banff classification and reversal of acute renal rejection.
    Kokado Y, Kyo M, Takahara S, Ichimaru N, Wang JD, Toki K, Miki T, Okuyama A.
    Transplant Proc; 1998 Nov; 30(7):3064-6. PubMed ID: 9838350
    [No Abstract] [Full Text] [Related]

  • 6. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L, Chabannier MH, Modesto A, Rouzaud A, Cisterne JM, Tkaczuk J, Durand D.
    Am J Nephrol; 1999 Nov; 19(6):634-40. PubMed ID: 10592356
    [Abstract] [Full Text] [Related]

  • 7. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K, Munn SR, Sterioff S.
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract] [Full Text] [Related]

  • 8. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
    Dunn JF, Hatch J, Precht A, Hart M, Li S.
    Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
    [No Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K, Irie A, Mashimo S, Endo T, Koshiba K.
    Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
    Kehinde EO, Feehally J, Scriven SD, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
    [No Abstract] [Full Text] [Related]

  • 11. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ, Bannister KM, Russ GR, Mathew TH, Clarkson AR.
    Transplant Proc; 1999 Jun; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract] [Full Text] [Related]

  • 12. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
    Cronin DC, Bruce DS, Newell KA, Josephson MA, Millis JM, Piper JB, Ruebe M, Kirby M, Thistlethwaite JR, Woodle ES.
    Transplant Proc; 1997 Jun; 29(1-2):307. PubMed ID: 9123010
    [No Abstract] [Full Text] [Related]

  • 13. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V, Radermacher J, Hiss M, Pethig M, Burg M, Brunkhorst R.
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 16. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
    Meijer RT, Keur I, Surachno S, ten Berge IJ, Schellekens PT.
    Transplant Proc; 2001 May; 33(3):2196-7. PubMed ID: 11377501
    [No Abstract] [Full Text] [Related]

  • 17. Importance of degree of eosinophilia in inflammatory infiltrates within renal allografts in the response to immunosuppressive treatment.
    Papadimitriou JC, Nogueira J, Fink JC, Klassen DK, Bartlett ST, Weir MR, Drachenberg CB.
    Transplant Proc; 1998 Jun; 30(4):1181. PubMed ID: 9636477
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of steroid resistant acute rejection after renal transplantation.
    Oh CK, Kim YS, Kim MS, Kim SI, Park K.
    Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
    [No Abstract] [Full Text] [Related]

  • 19. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES, Thistlethwaite JR, Haas M, Josephson MA, Newell KA, Bruce DS, Millis JM, Piper JB, Charette JI.
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract] [Full Text] [Related]

  • 20. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
    Carl S, Dörsam J, Mandelbaum A, Staehler G, Wiesel M.
    Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.